Amneal Pharmaceuticals Financial Ratios
NASDAQ: AMRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Amneal Pharmaceuticals ratio analysis
Amneal Pharmaceuticals earned a net margin of 2.4% in FY 2025, up from -4.2% a year earlier. Gross margin was 36.9% compared with a median of 36.5% over the prior 9 years. At the end of FY 2025, AMRX traded at 57.5 times earnings; across the 3 fiscal years shown, its year-end P/E ranged from 7.5 to 68.4, with a median of 57.5.
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Amneal Pharmaceuticals financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 57.55 | — | — | — | 68.43 | 7.49 | — | — | — | — |
| Price / sales | 1.31 | 0.86 | 0.45 | 0.14 | 0.34 | 0.34 | 0.38 | 1.14 | — | — |
| Price / book | — | — | 54.05 | 1.01 | 1.98 | 2.22 | 2.69 | 3.74 | — | — |
| Gross margin | 36.9% | 36.5% | 34.3% | 35.5% | 36.7% | 31.5% | 21.7% | 43.1% | 50.9% | 58.7% |
| Operating margin | 13.1% | 8.9% | 8.5% | -4.3% | 7.3% | 4.6% | -15.3% | -1.2% | 23.7% | 28.0% |
| Net margin | 2.4% | -4.2% | -3.5% | -12.2% | 0.6% | 3.4% | -37.1% | -1.2% | 0.0% | 0.0% |
| Free cash flow margin | 8.9% | 8.7% | 12.6% | 0.8% | 9.3% | 16.2% | -2.8% | 10.1% | 13.5% | -0.8% |
| Return on equity (ROE) | — | — | -424.6% | -90.7% | 3.7% | 22.4% | -260.1% | -3.9% | — | — |
| Return on assets (ROA) | 2.0% | -3.3% | -2.4% | -7.1% | 0.3% | 1.7% | -16.5% | -0.5% | 0.0% | — |
| Debt / equity | — | — | 122.35 | 8.79 | 7.52 | 9.17 | 11.34 | 5.25 | — | — |
| Current ratio | 2.17 | 1.41 | 1.63 | 1.88 | 2.24 | 2.29 | 2.20 | 2.32 | 2.60 | — |
| Revenue growth | 8.0% | 16.7% | 8.2% | 5.7% | 5.1% | 22.5% | -2.2% | 60.9% | 1.5% | — |
| EPS growth | — | — | — | -1,328.6% | -88.5% | — | — | — | — | — |